Ep. 3: An Immunotherapy to Combat COVID-19

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/9b/6f/7e/9b6f7e67-5cc9-e18c-d117-1f9f2cf48c7d/mza_10212637187077793619.jpg/600x600bb.jpg

Phase 1

IPS-Integrated Project Services

9 episodes

4 days ago

Phase 1 provides an upbeat take on career and industry insights to emerging professionals in the life sciences industry through interview series with a focus on the knowledge of subject matter experts. The interviews focus on the career journeys of top industry influencers, current events, new technologies in the life sciences industry, and where the industry is heading.

Science

RSS

All content for Phase 1 is the property of IPS-Integrated Project Services and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/4466045/4466045-1586526652179-6d1b5c872249c.jpg

Ep. 3: An Immunotherapy to Combat COVID-19

Phase 1

26 minutes 15 seconds

5 years ago

Ep. 3: An Immunotherapy to Combat COVID-19

Life as we know it has changed because of the COVID-19 pandemic. While a race to develop a vaccine is in full swing at some pharmaceutical companies, Komal Hatti, Sr. Process Architect, & Tom Rajala, Lead Process Engineer, work on a project for SAb Biotherapeutics that is developing a therapeutic to combat the virus. They turn to the help of none other than cows to harvest their antibodies - so cool! Learn about this exciting project in our third episode.

SAb Biotherapeutics' CEO, Eddie J. Sullivan, explains more about the project during his interview in the I AM BIO podcast episode titled "Herd Immunity."